About
Martin Smrcina is Executive Director of Medicinal Chemistry at Zafrens, with 23 years of industrial experience in organic and medicinal chemistry. His work spans synthetic organic chemistry, drug design, solid phase techniques, and peptide synthesis, including the design, synthesis, and characterization of compounds advanced from leads to clinical candidates. He has also taught organic chemistry, with a focus on organic synthesis, reaction mechanisms, and stereochemistry.
Founder at Zafrens
Intro paths
→
In turn, Martin can intro founders to Zafrens's investors below.
Zafrens's investors · 9
Acequia Capital (AceCap)Seattle · $100K – $5M checks · since 2021BlueYard CapitalBerlin · $500K – $5M checks · since 2021FoundersX VenturesSilicon Valley · since 2021Global BrainTokyo · $100K – $184M checks · since 2021HAWKTAILSan FranciscoIaso VenturesCambridge · since 2021imec.xpandLeuven · $270K – $5.4M checks · since 2021Prime Movers LabJackson · $2M – $30M checks · since 2021Raptor GroupMiami Beach · since 2021
Co-founders at Zafrens
MN
Maina Ndungu
Experience
- ZafrensExecutive Director - Medicinal Chemistrycurrent2024 — presentSan Diego, California, United States
- ZafrensAssociate Research Fellowcurrent2023 — presentSan Diego, California, United States
- Icagen-Omniab Inc.Associate Research Follow2022 — 2023Tucson, Arizona, United States
- Icagen - Ligand companyAssociate Research Fellow2020 — 2022Tucson, Arizona, United States
- IcagenLead Research Investigator2016 — 2020Tucson, Arizona Area
- IcagenSenior Researcher2016
- SanofiLead Research Investigator2011 — 2016Tucson, Arizona Area
- SanofiPrincipal Research Investigator2005 — 2011Tucson, Arizona Area
- AventisPrincipal Research Investigator2000 — 2005Tucson, Arizona Area
- Hoechst Marion RousselResearch Investigator1997 — 2000Tucson, Arizona Area
- Department of Chemistry, Faculty of Science, Charles UniversityAssistant Professor of Chemistry1990 — 1996Prague, The Capital, Czech Republic
Skills & more
Medical ResearchAnalytical ChemistryResearch SkillsNMR SpectroscopyIR SpectroscopyLC-MSNMR spectrometryMedicinal Chemistry4Clinical ResearchChemistry2Organic Chemistry1Pharmaceutical Industry
+10 more
Drug DesignPeptidesDrug DiscoveryDrug DevelopmentADMEOrganic SynthesisPeptide SynthesisSynthetic Organic ChemistryHigh-Performance Liquid Chromatography (HPLC)Liquid Chromatography-Mass Spectrometry (LC-MS)Languages Czech · English
From Martin's professional profile.
Frequently asked questions
- Who is Martin Smrcina?
- Martin Smrcina is Executive Director of Medicinal Chemistry at Zafrens, with 23 years of industrial experience in organic and medicinal chemistry. His work spans synthetic organic chemistry, drug design, solid phase techniques, and peptide synthesis, including the design, synthesis, and characterization of compounds advanced from leads to clinical candidates. He has also taught organic chemistry, with a focus on organic synthesis, reaction mechanisms, and stereochemistry.
- Where does Martin Smrcina work?
- Martin Smrcina is Founder of Zafrens.
- What companies did Martin Smrcina found?
- Martin Smrcina founded Zafrens.
- Where did Martin Smrcina go to school?
- Martin Smrcina studied at Cornell University (Ph.D. Postdoc, Organic Chemistry); Charles University (Master's degree and Ph.D., Organic Chemistry).
Same school
Also attended Cornell University748
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerJenny LeeSenior Managing Partner at Granite AsiaNeeraj AgrawalGeneral Partner at Battery VenturesJohn ZimmerCo-founder of LyftMichelle FernandesInvestor at Index VenturesMicah RosenbloomGeneral Partner at Founder Collective
+ 742 more
Also attended Charles University62
Taylor McPartland<UNKNOWN> at Pave Health VenturesKarel TušekManaging Partner at Tachles VCDimitri UhlikManaging Director at CaliberSteven PeraltaVP, Investments at Acumen AmericaMax PalkoPrincipal at Rockaway VenturesKateřina HavrlantOperating Partner at Rockaway Ventures
+ 56 more
Shared employers
Also worked at Zafrens5
Also worked at Sanofi95
Walter OlesiakOperating Partner at Remiges Ventures, Inc.Christine AylwardFounder & Managing Partner at Magnetic VenturesAlan WaltsVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityMatt VineSenior Associate at RRE VenturesWalter OlesiakOperating Partner at RDiscovery
)
+ 89 more